THE PROGNOSTIC VALUE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN PREDICTING IN-HOSPITAL OUTCOMES FOR PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME
Main Article Content
Keywords
Neutrophil-to-lymphocyte ratio (NLR), Non-ST-elevation acute coronary syndrome, Inflammatory biomarkers, In-hospital outcomes
Abstract
Objective: To investigate the association between admission neutrophil-to-lymphocyte ratio (NLR) and clinical outcomes during hospitalization in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) at a major cardiac center in Pakistan.
Study Design: A cross-sectional study
Place and Duration: This study was conducted at Peoples University of Medical and Health Sciences for Women Shaheed Benazirabad Nawabshah from November 2023 to November 2024
Methods: This study enrolled 156 patients aged 18–80 years with NSTE-ACS (unstable angina or non-ST-elevation myocardial infarction [NSTEMI]) after ethical approval and informed consent. NLR was calculated from admission blood samples and stratified as low-risk (<3.0), intermediate-risk (3.0–6.0), and high-risk (>6.0). Outcomes included symptom profiles, ejection fraction, arrhythmias, contrast-induced nephropathy (CIN), and mortality. Data were analyzed using IBM SPSS version 21, with statistical significance at p<0.05.
Results: Of 156 patients (60.3% male, mean age 51–60 years), 51.3% (n=80) were low-risk, 32.1% (n=50) intermediate-risk, and 16.6% (n=26) high-risk. Significant differences included shortness of breath prevalence (19.4% low-risk vs. 42.3% high-risk; p=0.004), ejection fraction (20–40%: 28.8% low-risk vs. 53.8% high-risk; p=0.019), neutrophils (60±8.90% low-risk vs. 85±3.00% high-risk; p<0.001), and lymphocytes (33.5±7.02% low-risk vs. 9.5±2.25% high-risk; p<0.001). In-hospital trends showed arrhythmias (3.8% low-risk vs. 12.5% high-risk; p=0.073), CIN (2.5% low-risk vs. 9.6% high-risk; p=0.078), and mortality (1.3% low-risk vs. 3.8% high-risk; p=0.263), with uniform hospital stays (median 3 days; p=0.311).
Conclusion: Elevated NLR is associated with worse symptom severity, reduced ejection fraction, and trends toward increased complications in NSTE-ACS, supporting its prognostic value in resource-limited settings. Larger studies are needed for validation.
References
2. Raheem, A., et al., Burden of cardiovascular diseases in South Asian region from 1990 to 2019: Findings from the global burden of disease study. Pakistan Heart Journal, 2022. 55(1): p. 15-21.
3. Levine, G.N., et al., 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. Journal of the American College of Cardiology, 2016. 67(10): p. 1235-1250.
4. Mitsis, A. and F. Gragnano, Myocardial Infarction with and without ST-segment Elevation: a Contemporary Reappraisal of Similarities and Differences. Current cardiology reviews, 2021. 17(4): p. 49-58.
5. Robbins, J. and E.V. Gelfand, Unstable Angina and Non-ST Elevation Myocardial Infarction, in Comprehensive Cardiovascular Medicine in the Primary Care Setting. 2018, Springer. p. 233-259.
6. Carella, M.C., et al., Intersections and Challenges in the Management of Acute Coronary Syndrome and Stroke: Pathophysiology, Treatment Dilemmas, and Integrated Prevention Strategies. Journal of Clinical Medicine, 2025. 14(7): p. 2354.
7. Medina-Leyte, D.J., et al., Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. International journal of molecular sciences, 2021. 22(8): p. 3850.
8. Kandibendla, V., et al., Correlation of neutrophil to lymphocyte ratio to severity of coronary artery disease and in-hospital clinical outcomes in patients with acute coronary syndrome: A prospective observational study. Journal of Acute Disease, 2024. 13(1).
9. Gosav, E.M., et al. The Prognostic Role of the Neutrophil-to-Lymphocytes Ratio in the Most Frequent Cardiovascular Diseases: An Update. Life, 2024. 14, DOI: 10.3390/life14080985.
10. Siregar, B.Y., R. Hasan, and R. Isnanta, Association of Neutrophil Lymphocyte Ratio (NLR) with Global Registry of Acute Coronary Events (GRACE) Scores in Acute Coronary Syndrome. Journal of Endocrinology, Tropical Medicine, and Infectious Disease (JETROMI), 2020. 2(3): p. 162-170.
11. Węgiel, M., et al., Neutrophil-to-lymphocyte ratio as a predictor of left ventricle function and mortality in patients with myocardial infarction. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 2025. 21(1).
12. Jiang, R., et al., Association between neutrophil-lymphocyte ratio levels and mortality related to cardiovascular cause and all causes in coronary artery disease patients with low-density lipoprotein cholesterol below 1.4 mmol/L: A multicenter cohort study. Nutrition, Metabolism and Cardiovascular Diseases, 2025: p. 104058.
13. Pruc, M., et al., Diagnostic and prognostic performance of the neutrophil-to-lymphocyte ratio in acute coronary syndromes: A meta-analysis of 90 studies including 45 990 patients. Polish Heart Journal (Kardiologia Polska), 2024. 82(3): p. 276-284.
14. Shahsanaei, F., et al., The value of neutrophil-to-lymphocyte ratio in predicting severity of coronary involvement and long-term outcome of percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis. The Egyptian Heart Journal, 2024. 76(1): p. 39.
15. Adamstein, N.H. and P.M. Ridker, The neutrophil–lymphocyte ratio: considerations for clinical application. European heart journal, 2021. 42(22): p. 2216-2217.
16. Avci, B.Ş., et al., The Effectiveness of Neutrophil‐Lymphocyte Ratio in Predicting in‐Hospital Mortality in Non‐ST‐Elevation Myocardial Infarction. Emergency medicine international, 2020. 2020(1): p. 8718304.
17. Zengin, A., et al., Performance of neutrophil to lymphocyte ratio for the prediction of long-term morbidity and mortality in coronary slow flow phenomenon patients presented with non-ST segment elevation acute coronary syndrome. Journal of Cardiovascular and Thoracic Research, 2021. 13(2): p. 125.
18. Yang, Y., et al., The correlation between serum MHR and NLR and the severity of coronary lesions in NSTE-ACS patients of different genders. Frontiers in Cardiovascular Medicine, 2025. 11: p. 1469730.
19. Banahene, N.O., et al., Effect of elevated neutrophil-to-lymphocyte ratio on adverse outcomes in patients with myocardial infarction: a systematic review and meta-analysis. Cureus, 2024. 16(6).
20. Lin, G., et al., Predictive value of neutrophil to lymphocyte ratio and red cell distribution width on death for ST segment elevation myocardial infarction. Scientific Reports, 2021. 11(1): p. 11506.
21. Zhang, J.-l., et al., Association between the neutrophil-to-lymphocyte ratio and risk of in-hospital heart failure and arrhythmia in patients with acute myocardial infarction. Frontiers in Cardiovascular Medicine, 2023. 10: p. 1275713.
22. Ösken, A., et al., The association between neutrophil-to-lymphocyte ratio and contrast-induced acute kidney injury in patients with carotid artery stenting. Vascular, 2021. 29(4): p. 550-555.
23. Jalbani, J., et al., The role of neutrophil to lymphocyte ratio and its common clinical outcomes among patients with non-ST elevation acute coronary syndrome. Journal of the Saudi Heart Association, 2023. 35(2): p. 177.
24. Diniz, L.R., et al., Neutrophil to Lymphocyte Ratio as a Prognostic Predictor in Older People With Acute Coronary Syndrome. Angiology, 2018. 70(3): p. 264-271.